Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel).
Eyre TA, Preston G, Kagdi H, Islam A, Nicholson T, Smith HW, Cursley AP, Ramroth H, Xing G, Gu L, Rajakumaraswamy N, Fegan C. Eyre TA, et al. Among authors: kagdi h. Br J Haematol. 2021 Jul;194(1):69-77. doi: 10.1111/bjh.17475. Epub 2021 Jun 14. Br J Haematol. 2021. PMID: 34121184 Free PMC article.
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
Garnett C, Foldes D, Bailey C, Nesr G, Hui T, Hinton R, Gurung K, Phillips J, Saleem Z, Koshy R, Aduwa E, Colis M, Bimolah R, Katsomitrou V, Arami S, Kagdi H. Garnett C, et al. Among authors: kagdi h. Leuk Lymphoma. 2021 Feb;62(2):469-472. doi: 10.1080/10428194.2020.1838506. Epub 2020 Nov 9. Leuk Lymphoma. 2021. PMID: 33167718 No abstract available.
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust.
Hinton R, Nesr G, Garnett C, Foldes D, McCay JJR, Medland R, Kagdi H, Katsomitrou V, Sim HW, Gandhi S, Parcharidou A, Arami S. Hinton R, et al. Among authors: kagdi h. Leuk Lymphoma. 2022 Jan;63(1):227-230. doi: 10.1080/10428194.2021.1973671. Epub 2021 Sep 2. Leuk Lymphoma. 2022. PMID: 34470547 No abstract available.
Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
Subramanian K, Dierckx T, Khouri R, Menezes SM, Kagdi H, Taylor GP, Farre L, Bittencourt A, Kataoka K, Ogawa S, Van Weyenbergh J. Subramanian K, et al. Among authors: kagdi h. Int J Cancer. 2019 Apr 1;144(7):1664-1675. doi: 10.1002/ijc.31922. Epub 2018 Dec 18. Int J Cancer. 2019. PMID: 30303535 Free PMC article.